« Back to Record
Citation APA

Sotiriou, C., Loi, S., Haibe-Kains, B., Lallemand, F., Pusztai, L., Bardelli, A., Bedard, P. L., Ellis, M. J. C., Phillips, W., Piccart-Gebhart, M., & McArthur, G. A. (2009). PIK3CA mutation-associated gene expression signature correlates with deactivation of the PI3K pathway and predicts benefit to endocrine therapy in high-risk ER+ (luminal B) breast cancers (BC). Paper session presented at AACR Annual Meeting (April 18-22, 2009: Denver, USA).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/244709

Sotiriou, C., Loi, S., Haibe-Kains, B., Lallemand, F., Pusztai, L., Bardelli, A., Bedard, P. L., Ellis, M. J. C., Phillips, W., Piccart-Gebhart, M., & McArthur, G. A. (2009). PIK3CA mutation-associated gene expression signature correlates with deactivation of the PI3K pathway and predicts benefit to endocrine therapy in high-risk ER+ (luminal B) breast cancers (BC). Paper session presented at AACR Annual Meeting (April 18-22, 2009: Denver, USA).